Boenning & Scattergood’s iShares Biotechnology ETF IBB Stock Holding History

Boenning & Scattergood’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$301K	Sell	2,311 -1,850	-44%	-$239K	0.05%	323
2022 Q3	$487K	Buy	4,161 +160	+4%	+$19.9K	0.1%	228
2022 Q2	$471K	Buy	4,001 +1,690	+73%	+$201K	0.09%	230
2022 Q1	$301K	Sell	2,311 -121	-5%	-$15.8K	0.05%	323
2021 Q4	$371K	Sell	2,432 -47	-2%	-$7.28K	0.06%	294
2021 Q3	$400K	Buy	2,479 +145	+6%	+$24.4K	0.07%	270
2021 Q2	$382K	Buy	2,334 +105	+5%	+$16.2K	0.07%	272
2021 Q1	$336K	Buy	2,229 +375	+20%	+$59.6K	0.06%	278
2020 Q4	$281K	Sell	1,854 -30	-2%	-$4.29K	0.06%	283
2020 Q3	$255K	Buy	+1,884	New	+$256K	0.06%	275
2019 Q1	–	Sell	-11,674	Closed	-$1.13M	–	282
2018 Q4	$1.13M	Buy	+11,674	New	+$1.24M	0.39%	74

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boenning & Scattergood's IBB Position: Q4 2022 in Review

Boenning & Scattergood reduced its iShares Biotechnology ETF (IBB) stake by 44% in Q4 2022, selling an estimated $239K and leaving 2,311 shares worth $301K. The position accounts for 0.05% of the portfolio, ranked #323.

Boenning & Scattergood first reported a position in IBB in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.13M in Q4 2018. 902 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Boenning & Scattergood held 2,311 shares of iShares Biotechnology ETF worth $301K as of Q4 2022.
Boenning & Scattergood sold 1,850 iShares Biotechnology ETF shares in Q4 2022, an estimated $239K.
iShares Biotechnology ETF made up 0.05% of Boenning & Scattergood's portfolio in Q4 2022, its #323 holding.
Boenning & Scattergood first reported a position in iShares Biotechnology ETF in Q4 2018 and has held it in 11 quarters since.
Boenning & Scattergood's iShares Biotechnology ETF position peaked at $1.13M in Q4 2018.
902 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.